Dually-registered advisers on SEC focus list

Regulator also will focus examinations on payments that advisers and funds make to companies that distribute private equity and hedge funds

By Mark Schoeff Jr.

Feb 24, 2013 @ 12:01 am (Updated 6:35 pm) EST

Bloomberg

Investment advisers to private-equity and hedge funds, and those who are dually registered as broker-dealers, will be targeted by Securities and Exchange Commission examiners this year.

The SEC also will focus examinations on payments that advisers and funds make to companies that distribute the funds, and will explore the use of alternative and hedge funds in exchange-traded funds and variable annuities. The review priorities were posted on the SEC website last Thursday.

SALES, COMPLIANCE

For broker-dealers, among the areas the SEC will target are fraudulent sales practices used with retail investors and compliance with the agency's new market access rule.

The agency is putting an emphasis on reviewing investment advisers who are dually registered as brokers because of the convergence of the two practices. The agency is concerned that investors could be harmed as the lines between the two blur.

The SEC also is keeping an eye on payments that advisers and fund companies make for fund distribution, a practice that is labeled in the report as “payments for distribution in guise.”

The SEC is providing the guidance on examinations so that advisers are not caught by surprise.

  @IN Wire

Apr 23 05:28PM
Raymond James reports strong quarter in private-client group http://t.co/kFy27dTkB5
Apr 23 05:24PM
Industry groups give failing marks to proposal that would publicize broker exam scores http://t.co/g00aswoswu via @MarkSchoeff

Career Center

Explore your opportunities and be informed for your next move.

Company Type
Firm Type
Clearing Firm
Presented by

Most Watched Video

7:12The 2 biggest factors driving growth in active ETFs

Ugo W. Egbunike Dir. Of Business Development, ETF.com Greg Crawford Deputy Editor, InvestmentNews

Video Spotlight
1:47People are Living Longer. Good News or Bad News?

Sponsored by Oppenheimer Funds Inc.